University Hospital, Grenoble

This early-phase study tests whether adding a new drug called NP137 to the standard two-drug therapy (Atezolizumab and Bevacizumab) can help shrink tumors and extend life in people with advanced liver cancer that cannot be removed by surgery. About 43 adults with this type of liv…

This study tests a new way to deliver extra radiation (boost) directly to prostate tumors using a 3D ultrasound guidance system. Fifteen men with low- or favorable intermediate-risk prostate cancer will receive standard brachytherapy plus up to 4 extra iodine-125 implants placed …

This study offers children and teens with cancer a personalized exercise program with a trained professional. The goal is to see if kids stick with the program for 4 to 6 months during their cancer treatment. Researchers will ask children and parents about what motivates them and…

This study looks at whether a simple ultrasound test (TCD) can safely identify mild traumatic brain injury patients who can go home right away instead of staying in the hospital. About 550 adults with mild head injuries will be randomly assigned to either the ultrasound-based dec…